Cornell Scientists Develop Reversible Male Birth Control

Breakthrough mouse study shows compound can temporarily halt sperm production without lasting harm.

Apr. 8, 2026 at 12:54am

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray photograph revealing the intricate internal structure of a human testicle, with glowing blue and gray lines defining the seminiferous tubules where sperm are produced, conceptually illustrating the breakthrough in male contraceptive research.An X-ray view into the inner workings of the male reproductive system, where a new nonhormonal contraceptive compound could temporarily halt sperm production.Ithaca Today

Researchers at Cornell University have made a major advancement toward developing a safe, reversible, and highly effective nonhormonal male contraceptive. In a six-year mouse study, scientists used a compound called JQ1 to temporarily disrupt meiosis, the critical process that produces sperm, without causing lasting damage. After treatment stopped, sperm production and fertility returned to normal, and the animals went on to produce healthy offspring.

Why it matters

Current male contraceptive options remain limited to condoms and vasectomies, which many men are hesitant to undergo. Researchers have also been cautious about developing hormonal approaches due to safety concerns. This new approach targeting meiosis could provide an alternative that is both highly effective and reversible, meeting a longstanding need for new male birth control methods.

The details

The Cornell team focused on disrupting meiosis, the process that produces sperm cells, rather than targeting other stages of sperm development. This allowed them to completely halt sperm production while still preserving overall reproductive health. The compound JQ1 works by interfering with prophase 1 of meiosis, causing developing cells to die at that stage and blocking the gene activity required for later sperm development. After three weeks of JQ1 treatment, the male mice experienced a complete stop in sperm production, but within six weeks of ending the treatment, normal meiotic processes and healthy sperm production had returned.

  • The study was conducted over a six-year period.
  • The male mice received JQ1 treatment for three weeks.
  • Within six weeks of ending the treatment, the mice had regained normal sperm production and fertility.

The players

Cornell University

The Ivy League research university where the scientists conducting this breakthrough male contraceptive research are based.

Paula Cohen

A professor of genetics and the director of the Cornell Reproductive Sciences Center, who led the research team.

JQ1

A small molecule inhibitor originally developed to study cancer and inflammatory diseases, which was used in the study to temporarily disrupt meiosis and halt sperm production.

Got photos? Submit your photos here. ›

What they’re saying

“We're practically the only the group that's pushing the idea that contraception targets in the testis are a feasible way to stop sperm production.”

— Paula Cohen, Professor of Genetics and Director of the Cornell Reproductive Sciences Center

“Our study shows that mostly we recover normal meiosis and complete sperm function, and more importantly, that the offspring are completely normal.”

— Paula Cohen, Professor of Genetics and Director of the Cornell Reproductive Sciences Center

What’s next

If developed for human use, this type of male contraceptive could be delivered as an injection given every three months or possibly as a patch to maintain effectiveness.

The takeaway

This breakthrough research represents a major step toward providing men with a safe, reversible, and highly effective nonhormonal contraceptive option, meeting a longstanding need for new male birth control methods beyond condoms and vasectomies.